Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: Preliminary results
R. Komaki(The University of Texas MD Anderson Cancer Center), Lee J.S.(The University of Texas MD Anderson Cancer Center), B. Kaplan(The University of Texas MD Anderson Cancer Center), Pamela K. Allen(The University of Texas MD Anderson Cancer Center), Kelly J.F.(The University of Texas MD Anderson Cancer Center), Zhongxing Liao(The University of Texas MD Anderson Cancer Center), Stevens C.W.(The University of Texas MD Anderson Cancer Center), Fossella F.V.(The University of Texas MD Anderson Cancer Center), Ralph Zinner(The University of Texas MD Anderson Cancer Center), V. Papadimitrakopoulou(The University of Texas MD Anderson Cancer Center), Fadlo R. Khuri(The University of Texas MD Anderson Cancer Center), Bonnie S. Glisson(The University of Texas MD Anderson Cancer Center), K. Pisters(The University of Texas MD Anderson Cancer Center), Jonathan M. Kurie(The University of Texas MD Anderson Cancer Center), Roy Herbst(The University of Texas MD Anderson Cancer Center), Luka Milas(The University of Texas MD Anderson Cancer Center), Ro J.(The University of Texas MD Anderson Cancer Center), Thames H.D.(The University of Texas MD Anderson Cancer Center), Hong W.K.(The University of Texas MD Anderson Cancer Center), Cox J.D.(The University of Texas MD Anderson Cancer Center)
Cited by 95
Abstract
Related Papers
Cancer Statistics, 2001
Robert T. Greenlee, M. B. Hill-Harmon, Thomas S. Murray et al.|CA A Cancer Journal for Clinicians|2001|3.3k
Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial
R O Dillman, James E. Herndon, Stephen L. Seagren et al.|JNCI Journal of the National Cancer Institute|1996|932
Radiotherapy Alone Versus Combined Chemotherapy and Radiotherapy in Nonresectable Non-Small-Cell Lung Cancer: First Analysis of a Randomized Trial in 353 Patients
Thierry Le Chevalier, R. Arriagada, Élisabeth Quoix et al.|JNCI Journal of the National Cancer Institute|1991|804